Koyfin Home > Directory > Health Care > Amphastar Pharma > Other Liabilities

Amphastar Pharma Other Liabilities Chart (AMPH)

Amphastar Pharma annual/quarterly Other Liabilities from 2014 to 2018.
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the last 12 months ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Annual Other Liabilities for 2018 was $10m a 10.46% increase of 1m from 2017
  • Amphastar Pharma Annual Other Liabilities for 2017 was $9m a 40.75% increase of 4m from 2016
  • Amphastar Pharma Annual Other Liabilities for 2016 was $6m a 18.22% increase of 1m from 2015
Other Balance Sheet Metrics:
  • Amphastar Pharma Total Assets for the quarter ending December 12, 2018 was $514m a 12.42% increase of 64m year over year
  • Amphastar Pharma Total Equity for the quarter ending December 12, 2018 was $364m a 10.22% increase of 37m year over year
View Chart On Koyfin

Quarterly AMPH Other Liabilities Data

12/2018$10m
09/2018$10m
06/2018$10m
03/2018$10m
12/2017$9m
09/2017$7m
06/2017$7m
03/2017$6m
12/2016$6m
09/2016$5m

Annual AMPH Other Liabilities Data

2018$10m
2017$9m
2016$6m
2015$5m
2014$9m
2013$12m